Construction and Identification of a Recombinant Lentiviral Vector Encoding Shrna Targeting Rat CBP Gene

杨简,江洪,陈思思,陈静,徐盛开,王继春
DOI: https://doi.org/10.3969/j.issn.1009-0126.2010.04.019
2010-01-01
Abstract:Objective To construct a recombinant lentiviral vector encoding shRNA targeting rat CREB binding protein(CBP) gene,and observe the effects of CBP gene silencing in rat vascular smooth muscle cells (VSMCs).Methods Four shRNA sequences targeting CBP gene were designed and synthesized,and the best one was cloned into the pFU-GW-iRNA vector to construct the lentiviral expression vector containing CBP shRNA(LV-CBP shRNA).LV-CBP shRNA confirmed by PCR and DNA sequencing was subsequently cotransfected with packaging plasmids into 293T cells by Lipofectamine 2000.The titer of virus was detected according to the expression of enhanced green fluorescent protein(EGFP).CBP mRNA expression in VSMCs with or without lentivirus transiection was measured by real-time PCR.Results PCR analysis and DNA sequencing demonstrated that the LV-CBP shRNA was constructed successfully.The titer of concentrated lentivirus was 2×10~9TU/ml.Compared with non-transfectd VSMCs and LV-NC shRNA,the level of CBP mRNA in LV-CBP shRNA decreased by 88.5%,92.7%,respectively.Conclusion The recombinant lentiviral vector encoding shRNA targeting CBP was successfully constructed. LV-CBP shRNA has obvious effect on CBP gene silencing in VSMCs,which provides the basis for future gene therapy of vascular proliferative disease.
What problem does this paper attempt to address?